INTRODUCTION
The integrin family of cell surface receptors plays critical roles in multiple biological functions (Hynes, 1992) . The integrins are noncovalently associated heterodimers whose extracellular domains bind either components of the extracellular matrix (ECM)1 or other cell surface receptors (Albelda and Buck, 1990) , while the cytoplasmic domains bind specific components of the actin cytoskeleton. Thus integrins appear to provide a structural linkage between the extracellular environment and the cellular cytoplasm (re-cellular matrix; FAK or pp125FAK, focal adhesion kinase; FAT, focal adhesion targeting; GST, glutathione-S-transferase; GuHCl, guanidine hydrochloride; HMK, heart muscle kinase; RIPA, radioimmunoprecipitation assay buffer; SDS-PAGE, sodium dodecyl sulfatepolyacrylamide gel electrophoresis; SH2 domain, Src-homology 2 domain; SH3 domain, Src-homology 3 domain; Simian virus 40, SV40. viewed in Burridge et al., 1988; Turner and Burridge, 1991) . Mounting evidence indicates that integrin-ECM interactions function beyond the role of cell/cytoskeletal anchorage because these interactions induce intracellular phenomena classically attributed to activation of signal cascades (reviewed in Hynes, 1992;  Schwartz, 1992; Juliano and Haskill, 1993) . Integrin binding to ECM or cross-linking of cell surface integrin leads to a pronounced increase in the tyrosine phosphorylation of focal adhesion kinase pp125FAK (Guan et al., 1991; Burridge et al., 1992; Hanks et al., 1992; Kornberg et al., 1992; Schaller et al., 1993 ) and a concomitant increase in its in vitro catalytic activity (Guan and Shalloway, 1992; Lipfert et al., 1992) . Therefore, ppI25FAK is a candidate for mediating signal transduction after integrin-ligand interactions.
Focal adhesion kinase is comprised of three domains, a central catalytic domain flanked by aminoand carboxy-terminal noncatalytic domains that lack Src-homology 2 (SH2) and Src-homology 3 (SH3) domains. We have previously demonstrated that a 159-amino acid domain (the focal adhesion-targeting sequence or FAT sequence) within the carboxy-terminus J.D. Hildebrand et al. of pp125FAK is required for proper subcellular localization to focal adhesions, presumably by mediating an interaction with another cytoskeletal protein (Hildebrand et al., 1993) . Furthermore, in vivo and in vitro experiments have demonstrated that pp125FAK undergoes autophosphorylation, predominantly on a single tyrosine T3yi997 . Phosphorylation of Tyr 7 creates a high affinity binding site for SH2 containing proteins, including pp6Osrc and p59fyf (Cobb et al., 1994; Schaller et al., 1994) , thus providing a mechanism for the recruitment of kinases and other SH2 domain-containing proteins to focal adhesions.
Paxillin is a 68,000-75,000 dalton focal adhesion protein originally identified in chicken embryo fibroblasts transformed by Rous sarcoma virus (Glenney and Zokas, 1989) . In addition to transformation by Rous sarcoma virus, a number of extracellular stimuli induce paxillin tyrosine phosphorylation, including neuropeptides (Zackary et al., 1993) , lysophosphatidic acid (Seufferlein and Rozengurt, 1994) , PDGF (Rankin and Rozengurt, 1994) , and fibronectin (Burridge et al., 1992) . These data imply that paxillin may be involved in multiple biological processes, with tyrosine phosphorylation modulating its function or activity. Interestingly, many of these same stimuli induce ppl25FAK tyrosine phosphorylation as well (Kumagai et al., 1993; Sinnett-Smith et al., 1993; Rankin and Rozengurt, 1994; Seufferlein and Rozengurt, 1994) . Paxillin has also been implicated in numerous protein-protein interactions, including associations with vinculin (Turner et al., 1990) , p47gag-crk , Csk (Sabe et al., 1994) , and pp6Osrc (Weng et al., 1993) . cDNAs encoding ppl25 K and ppl25FAK variants were introduced into CE cells using the replication competent retroviral expression vector RCAS A (BH) (Hughes et al., 1987; Hildebrand et al., 1993; Schaller et al., 1993) and the cells were lysed in modified radioimmunoprecipitation assay buffer (RIPA) (Hildebrand et al., 1993 were immunoprecipitated from 500 ,tg CE lysate using either the rabbit polyclonal serum BC3 or mAb 2A7 (Kanner et al., 1990) as described. Immune complexes were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (Laemmli, 1970) and Western blotting using either a paxillin-specific mAb (Transduction Laboratories, Lexington, KY), the pp125FAK-specific sera BC3 . FAK cDNA sequences encoding amino acid residues 687-1054 were cloned into the bacterial expression vector pGex2TK (Kaelin et al., 1992) . The Association of Paxillin with FAK was performed as described (Kaelin et al., 1992) . Construction of pp125FAK amino terminal deletion variants d131-144 and d151-377 and carboxy-terminal deletion variants d1721-857, d1853-963, and d1965-1012, has been described previously (Hildebrand et al., 1993) .
"Farwestern" Blotting (Gel-Overlay) CE cell lysate and protein complexes were resolved by SDS-PAGE and transferred to nitrocellulose. Nitrocellulose filters were denatured/renatured at 4°C as follows. Filters were incubated twice for 5 min in 100 ml hyb75 (20 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid [pH 7.71, 75 mM KCI, 0.1 mM EDTA, 2.5 mM MgCl2, 1 mM dithiothreitol, 0.05% NP-40) (Kaelin et al., 1992) plus 6 M guanidine hydrochloride (GuHCl). The filters were washed four times for 10 min per wash in 100 ml hyb75 containing 3 M GuHCl (a 1:1 dilution of the 6 M GuHCl solution). This step was repeated four times, each time using hyb75 containing a twofold dilution of the GuHCl from the previous wash step. Filters were transferred to new dishes and washed twice for 30 min in 100 ml hyb75. Filters were then blocked for 30 min in 10 ml hyb75 plus 5% milk, then 30 min in 10 ml hybridization solution plus 1% milk as described (Kaelin et al., 1992) . After the blocking step, 32P-labeled fusion protein was added (3 x 105 cpm/ml, specific activity of approximately 108 cpm/,ug) and the filters were incubated for 8 h at 4°C.
Filters were washed three times in 100 ml hyb75 plus 1% milk for 15 min at room temperature and exposed to film at -70°C with an intensifying screen. Generation of 32P-labeled GST-FAK probe was as follows. GST-Cterm (described above) was expressed in Escherichia coli, affinity purified using glutathione Sepharose, and phosphorylated in vitro using cAMP-dependent protein kinase catalytic subunit (PKA, Sigma Chemical, St. Louis, MO) as described (Kaelin et al., 1992) . Briefly, 3 mg of GST-Cterm coupled to beads was washed in heart muscle kinase (HMK) buffer (20 mM Tris [pH 7.5], 100 mM NaCl, 12 mM MgCl2), resuspended in 40 ml of HMK containing 1 mM dithiothreitol, 50 U PKA, and 100 ,uCi 32P--y-ATP (6000 Ci/mmol, Dupont NEN, Wilmington, DE), and incubated for 45 min at room temperature. Beads were subsequently washed once with 1 ml HMK stop buffer (10 mM sodium phosphate [pH 8.01, 10 mM sodium pyrophosphate, 10 mM EDTA) and five times with 1 ml Tris-buffered saline. GST fusion proteins were eluted twice at room temperature with constant rotation in 10 bed volumes of glutathione (20 mM glutathione, 100 mM Tris [pH 8.01, 120 mM NaCl).
A Immunofluorescence
For determining the subcellular localization of ppI25FAK mutants, CE cells expressing ppI25CFAK deletion variants were grown overnight on coverslips, fixed with 3.7% paraformaldehyde, permeabilized with 0.4% Triton X-100, and stained by indirect immunofluorescence with the mAb KT3 as previously described Wu et al., 1991 , Hildebrand et al., 1993 .
RESULTS

Co-Precipitation of Paxillin and ppl25FAK
Previous experiments demonstrated that sequences within the carboxy-terminal noncatalytic domain of pp125FAK were required for efficient localization to focal adhesions. To identify proteins that might physically complex with pp125FAK and direct subcellular localization, CE cells were infected with a replication competent retroviral vector designed to express pp125FAK (Hildebrand et al., 1993; Schaller et al., 1993). ppl25FAK immune complexes prepared from cell lysates of such cells were probed with specific antibodies to determine the presence of co-precipitating focal adhesion proteins. Immunoprecipitation of ppl25FAK with either the polyclonal antiserum BC3 or mAb 2A7 resulted in the coimmunoprecipitation of approximately 5-10% of the paxillin present in the cell lysate (Figure 1 ). The 44-kDa protein detected in the paxillin Western blots is suspected to be a proteolytic cleavage product of paxillin that contains both the binding site for pp125F K and the epitope for the paxillin-specific antibody. Paxillin was not immunoprecipitated by either preimmune rabbit serum or by rabbit antimouse IgG (Figure 1) To further characterize the ppl25FA -paxillin interaction, the location of the paxillin binding site within ppl25FAK was explored using a series of previously described pp125FAK deletion variants (Hildebrand et al., 1993) . Immune complexes of wild-type pp125FAK or pp125FAK amino-terminal deletion variants d131-144 and d151-377 contained equal amounts of paxillin demonstrating that paxillin did not bind within the amino-terminal domain of pp125FAK (our unpublished results). The carboxy-terminal deletion variant d1721-857 also stably associated with paxillin (our unpublished results). In contrast, a variant of pp125F , pp125 , in which amino acids 1041-1054 were replaced with an 11-amino acid nonhomologous epitope tag failed to complex with paxillin (Figures 1  and 3A ). This observation implicated the extreme carboxy-terminus of pp125FAK in the interaction with paxillin. Delineation of a paxillin binding site using coimmunoprecipitation was complicated by our previous observation that deletions between residues 857 and 1012 abolish the ability of pp125FAK to localize to cellular focal adhesions (Hildebrand et al., 1993) . Therefore, failure of various pp125FAK carboxy-terminal mutations to complex with paxillin may not necessarily be due to alteration of the paxillin binding To determine if the association of paxillin and pp125FAK was regulated, stable association was evaluated under conditions during which new focal adhesions were being formed. Normal, untransfected CE cells were plated on dishes coated with either poly-Llysine or fibronectin as described in MATERIALS AND METHODS. Cells were allowed to adhere and spread for the times indicated and were subsequently lysed. Endogenous pp125FAK was immunoprecipitated using BC3 and the immune complexes were evaluated by Western blotting. As seen in Figure 2 , pp125FAK tyrosine phosphorylation increased as cells adhered and spread on fibronectin, but not as cells adhered to poly-L-lysine. Conversely, the amount of paxillin bound to pp125FAK appeared to remain constant. These data indicate that the paxillin-ppl25FAK complex is stable, and not regulated in the same manner as pp125FAK tyrosine phosphorylation. Under these conditions tyrosine phosphorylation of paxillin was not detectable.
Paxillin and ppl25FAK Associate In Vitro
The previous experiments indicated that the paxillin binding site resided within the carboxy-terminal noncatalytic domain of pp125FAK, with the distal 13 residues being required for the interaction. To explore the association more thoroughly, we sought to establish this interaction in vitro using a GST fusion protein containinKg carboxy-terminal residues 687-1054 of ppl25FA (Cterm) ( Figure 3B ). CE lysates were incubated with Cterm fusion protein immobilized on glutathione-Sepharose beads, the beads were washed, and bound proteins were subsequently analyzed by Western blotting using a paxillin-specific mAb antibody. As shown in Figure 4 (lane 3), paxillin present in the lysate formed a stable complex with the carboxyterminus of pp125FAK. Conversely, no paxillin association was observed using immobilized GST alone (lane 2), indicating that paxillin binding was mediated by pp125FAK_specific sequences. By comparing the amount of paxillin detected by Western blotting in lane 1 with lanes 3 or 6, we estimate that approximately 10% of the paxillin in the CE lysates complexed with the fusion protein in vitro. Next, using a series of seven deletion variants of Cterm ( Figure 3B ), we attempted to elucidate the binding site for paxillin. Replacement of the final 13 residues of Cterm with unrelated sequences (Ctermctag) abolished paxillin binding (lane 4), thus confirming the co-precipitation experiments and implicating the extreme carboxy-terminal sequences of pp125FAX in paxillin binding. Similarly, a truncated variant of Cterm, CtermdllOll-1052, did not complex with paxillin (lane 5). Deletion of sequences 721-857 did not effect paxillin binding (lane 6), whereas several small deletions between residues 853 through 1035 abolished the ability of the carboxy-terminal domain to bind paxillin. These data indicated that either the binding site for paxillin resides within these sequences or these sequences are critical for maintaining the proper folding and/or conformation of the actual binding sequence.
Paxillin Binding to pp125FAK Is Direct
The above experiments did not establish whether the paxillin-ppl25FAK interaction is direct or indirect. To evaluate these possibilities, we employed farwestern blot/gel overlay analysis using in vitro-labeled Cterm. The Cterm fusion protein was isolated, labeled with 32P, and used to directly probe proteins immobilized on nitrocellulose membranes. As shown in Figure 5 , labeled Cterm bound a single detectable protein in total cell lysate ( Figure 5A, lane 1) . Similarly, 32P_ labeled fusion protein bound to a 68-kDa protein that associates with Cterm in vitro ( Figure 5A, lane 3) .
Conversely, the 32P-labeled fusion protein did not bind to any proteins that associate with GST alone ( Figure 5A , lane 2). To confirm that this protein was paxillin, immune complexes were prepared from 1 mg of total cell lysate using a paxillin-specific mAb and the complexes were subjected to farwestern analysis ( Figure 5B ). 32P-labeled Cterm bound to a 68-kDa protein that was immunoprecipitated by the anti-paxillin antibody ( Figure 5B, ciation of paxillin and pp125FAK. These sequences extensively overlap the sequences required for the correct subcellular localization of pp125FAK (Hildebrand et al., 1993) . However, the paxillin binding sequence and the FAT sequence can be functionally separated because replacement of the terminal 13 residues of pp125FAK disrupts paxillin binding but does not effect localization (Hildebrand et al., 1993; Schaller et al., 1993) . To further define the paxillin binding sequences and the FAT sequence, five nonoverlapping deletion mutations in the FAT sequence were generated by site-directed mutagenesis ( Figure 3A ). The resulting mutations were then assayed in vivo, in the context of ppl25cFAK, for an affect upon subcellular localization. Each of the five pp125CFAK deletion variants were initially evaluated by immunoprecipitation and Western blotting ( Figure 6 ). pp125CFAK deletion variants were expressed in CE cells, immunoprecipitated from 500 ,g total cell ble explanation for why paxillin binding and focal adhesion targeting activity are difficult to separate is that even small mutations completely disrupt the proper folding of the entire FAT sequence. Support for this hypothesis comes from efforts to map the epitope for the mAb 2A7 ( Figure 6 ). pp125FAK, pp125CFAK, or pp125cFAK deletion mutants were immunoprecipitated using BC3 and the immune complexes were evaluated by Western blotting using either KT3 ( Figure 6A ) or 2A7 ( Figure 6B ). As seen in Figure 6 , panel A, all of the ppl25cFAK variants expressed the epitope tag and were recognized by KT3 whereas wild-type pp125FAK was not recognized. Conversely, only pp125FAK, ppl25cFAK, and cFAKdl879-903 were recognized by 2A7 (Figure 6 , panel B). These data suggest that the epitope for 2A7 is dependent on the correct folding of the protein.
Interestingly, every mutation that ablates 2A7 recognition also effects focal adhesion localization and complexes. Immune complexes were prepared from 1 mg total cell lysate using a paxillin-specific mAb (lane 2) or rabbit anti-mouse (R-a-M) alone as a nonspecific control (lane 1). Immune complexes were subsequently resolved by SDS-PAGE and transferred to nitrocellulose. After transfer, filters corresponding to panels A and B were treated as described in MATERIALS AND METHODS, probed with 32P-labeled Cterm, washed, and exposed to film at -70°C.
Arrowheads denote paxillin. the engineered deletions perturb the conformation of the carboxy-terminus. Support for the latter hypothesis comes from studies of the mAb 2A7, the epitope for which appears to reside within the FAT sequence. Interestingly, any deletion mutation that perturbs both focal adhesion localization and paxillin binding also abrogates recognition by 2A7. These data suggest that the proper tertiary folding of this domain is crucial for its biological function.
A cDNA encoding the majority of paxillin has recently been cloned and sequenced (Turner and Miller, 1994 (Schmeichel and Beckerle, 1994) . Finally, the amino terminal portion of the protein appears to mediate the association of paxillin with both pp125FAK and vinculin in vitro (Turner and Miller, 1994 Recent evidence indicates that paxillin may function as an adapter protein serving to mediate the formation of multicomponent protein complexes. Paxillin has been shown to bind to the SH2 domains of the small adapter protein p47gag-crk ) and the protein tyrosine kinase Csk (Sabe et al., 1994) , to the SH3 domain of pp6Osrc (Weng et al., 1993) , and now to pp125FAK. By mediating the formation of extensive protein complexes, paxillin may help coordinate the transmission of cytoplasmic signals from focal adhesions. The pp125FAK/c-Src/ Csk/paxillin complex may function as a multimeric enzyme complex with both positive and negative regulatory components. It is well documented that paxillin becomes tyrosine phosphorylated after a variety of cellular stimuli (Glenney and Zokas, 1989; Burridge et al., 1992; Zackary et al., 1993; Rankin and Rozengurt, 1994; Seufferlein and Rozengurt, 1994) . In vitro experiments indicate that different kinases (e.g., Csk and Src) appear to phosphorylate paxillin on distinct sites (Schaller and Parsons, 1995) , potentially creating several distinct binding sites for specific SH2-containing signaling molecules. Thus, differential phosphorylation of paxillin by kinases such as pp125FAK pp6osrc, or Csk, could be converted into a variety of cytoplasmic signals, providing yet another level of regulation upon integrin signaling.
